Professor | Dong Qian | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Dong Qian
Contact Information	qiandong@ustc.edu.cn
Language ability	Chinese, English
Province	Anhui

Upload Avatar (500 x 500)

Name

Dong Qian

Contact Information

qiandong@ustc.edu.cn

Language ability

Chinese, English

Province

Anhui

University/Lab Affiliation and Title	University of Science and Technology of China
Faculty	Mayo Clinic College of Medicine
Academic Background & Achievements	2008-2013 Doctorate in Oncology: Sun Yat-sen University 2003-2008 Bachelor's in Clinical Medicine: Anhui Medical University Received 3 National Natural Science Foundation projects Published over 20 high-impact academic papers Led international and national multicenter clinical trials
Work Experience	2020-present Member, Chinese Anti-Cancer Association Radiation Therapy Committee 2021-present Youth Committee, Chinese Medical Association Radiation Oncology Branch 2019-present Director, Youth Council of Chinese Anti-Cancer Association 2019-present Member, Second Youth Committee of Chinese Medical Doctor Association Radiation Oncology Branch 2021-present Member, Chinese Research Hospital Association Radiation Oncology Committee 2020-present Member, Anhui Medical Association Oncology Branch 2020-present Member and Academic Secretary, Anhui Medical Association Radiation Therapy Branch 2021-present Executive Member, Esophageal Cancer Committee of Anhui Anti-Cancer Association 2022-present Member, Lung Cancer Committee of Anhui Anti-Cancer Association 2021-present Executive Member, Immunotherapy Committee of Anhui Clinical Oncology Association
Awards	Anhui Science and Technology Progress Award (2023): First Prize Tianjin Science and Technology Progress Award (2019): First Prize Jianghuai Famous Doctor Cultivation Project (2022): Outstanding Health Talent Tianjin 131 Innovative Talent (2018): Second Level Tianjin 131 Innovative Talent (2017): Third Level

University/Lab Affiliation and Title

University of Science and Technology of China

Faculty

Mayo Clinic College of Medicine

Academic Background & Achievements

2008-2013 Doctorate in Oncology: Sun Yat-sen University
2003-2008 Bachelor's in Clinical Medicine: Anhui Medical University
Received 3 National Natural Science Foundation projects
Published over 20 high-impact academic papers
Led international and national multicenter clinical trials

Work Experience

2020-present Member, Chinese Anti-Cancer Association Radiation Therapy Committee
2021-present Youth Committee, Chinese Medical Association Radiation Oncology Branch
2019-present Director, Youth Council of Chinese Anti-Cancer Association
2019-present Member, Second Youth Committee of Chinese Medical Doctor Association Radiation Oncology Branch
2021-present Member, Chinese Research Hospital Association Radiation Oncology Committee
2020-present Member, Anhui Medical Association Oncology Branch
2020-present Member and Academic Secretary, Anhui Medical Association Radiation Therapy Branch
2021-present Executive Member, Esophageal Cancer Committee of Anhui Anti-Cancer Association
2022-present Member, Lung Cancer Committee of Anhui Anti-Cancer Association
2021-present Executive Member, Immunotherapy Committee of Anhui Clinical Oncology Association

Awards

Anhui Science and Technology Progress Award (2023): First Prize
Tianjin Science and Technology Progress Award (2019): First Prize
Jianghuai Famous Doctor Cultivation Project (2022): Outstanding Health Talent
Tianjin 131 Innovative Talent (2018): Second Level
Tianjin 131 Innovative Talent (2017): Third Level

Areas of Focus	Mechanisms of radiotherapy resistance and sensitization strategies in malignant tumors Immunoactivation effects of radiotherapy Tumor telomere biology
Publications	Definitive Chemoradiotherapy versus Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Who Achieved Clinical Complete Response when Induction Chemoradiation Finished: A Phase II Random, Dong Qian, Xi Chen, Xiaobin Shang, Yuwen Wang, Peng Tang, Dong Han, Hongjing Jiang, Chuangui Chen, Gang Zhao, Dejun Zhou, Fuliang Cao, Puchun Er, Wencheng Zhang, Xiaoxia Li, Tian Zhang, Baozhong Zhang, Yong Guan, Jun Wang, Zhiyong Yuan, Zhentao Yu, Ping Wang, Qingsong Pang, 2022 Tumor Remission and tumor-infiltrating lymphocytes during chemoradiotherapy: predictive and prognostic markers in locally advanced esophageal squamous cell carcinoma, Dong Qian, Yuwen Wang, Gang Zhao, Fuliang Cao, Puchun Er, Xi Chen, Jingjing Cheng, Wencheng Zhang, Xiaoxia Li, Baozhong Zhang, Yong Guan, Dejun Zhou, Jun Wang, Yunqing Kang, Hongjing Jiang, Zhentao Yu, Zhiyong Yuan, Ping Wang, Qingsong Pang, 2019 BIBR1532, a selective telomerase inhibitor, enhances radiosensitivity of non-small cell lung cancer through increasing telomere dysfunction and ATM/CHK1 inhibition, Ding X, Cheng J, Pang Q, Wei X, Zhang X, Wang P, Yuan Z, Qian D, 2019 NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc, Wang Y, Cheng J, Xie D, Ding X, Hou H, Chen X, Er P, Zhang F, Zhao L, Yuan Z, Pang Q, Wang P, Qian D, 2018 Anlotinib enhances the antitumor immunity of radiotherapy by activating cGAS/STING in non-small cell lung cancer, Dong Han, Jiajia Zhang, Yawei Bao, Lei Liu, Ping Wang, Dong Qian, 2022

Areas of Focus

Mechanisms of radiotherapy resistance and sensitization strategies in malignant tumors
Immunoactivation effects of radiotherapy
Tumor telomere biology

Publications

Definitive Chemoradiotherapy versus Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Who Achieved Clinical Complete Response when Induction Chemoradiation Finished: A Phase II Random, Dong Qian, Xi Chen, Xiaobin Shang, Yuwen Wang, Peng Tang, Dong Han, Hongjing Jiang, Chuangui Chen, Gang Zhao, Dejun Zhou, Fuliang Cao, Puchun Er, Wencheng Zhang, Xiaoxia Li, Tian Zhang, Baozhong Zhang, Yong Guan, Jun Wang, Zhiyong Yuan, Zhentao Yu, Ping Wang, Qingsong Pang, 2022
Tumor Remission and tumor-infiltrating lymphocytes during chemoradiotherapy: predictive and prognostic markers in locally advanced esophageal squamous cell carcinoma, Dong Qian, Yuwen Wang, Gang Zhao, Fuliang Cao, Puchun Er, Xi Chen, Jingjing Cheng, Wencheng Zhang, Xiaoxia Li, Baozhong Zhang, Yong Guan, Dejun Zhou, Jun Wang, Yunqing Kang, Hongjing Jiang, Zhentao Yu, Zhiyong Yuan, Ping Wang, Qingsong Pang, 2019
BIBR1532, a selective telomerase inhibitor, enhances radiosensitivity of non-small cell lung cancer through increasing telomere dysfunction and ATM/CHK1 inhibition, Ding X, Cheng J, Pang Q, Wei X, Zhang X, Wang P, Yuan Z, Qian D, 2019
NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc, Wang Y, Cheng J, Xie D, Ding X, Hou H, Chen X, Er P, Zhang F, Zhao L, Yuan Z, Pang Q, Wang P, Qian D, 2018
Anlotinib enhances the antitumor immunity of radiotherapy by activating cGAS/STING in non-small cell lung cancer, Dong Han, Jiajia Zhang, Yawei Bao, Lei Liu, Ping Wang, Dong Qian, 2022

Radiotherapy Resistance Sensitization Malignant Tumors Immunoactivation Effects Telomere Biology Mechanisms

Fei Wang - University of Science and Technology of China

Liting Qian - University of Science and Technology of China

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us